Cannabis Drug On Sale In Canada

The world's first cannabis-based drug has gone on sale in Canada, and the UK firm which developed it says it remains committed winning a UK sales licence. Sativex is a mouth spray for multiple sclerosis (MS) sufferers, who can use it to alleviate pain. GW Pharmaceuticals said it remains "committed to securing approval of Sativex across Europe and elsewhere". GW Pharmaceuticals has been asked to provide more data to support its application for a UK licence. Sativex contains the same active ingredients as cannabis - tetrahydrocannabinol and cannabidiol.